Thoroughbred Financial Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.43M Buy
6,905
+66
+1% +$23.5K 0.15% 136
2025
Q4
$2.24M Sell
6,839
-1,178
-15% -$374K 0.13% 148
2025
Q3
$2.26M Sell
8,017
-2
-0% -$580 0.14% 152
2025
Q2
$2.24M Sell
8,019
-4,374
-35% -$1.24M 0.16% 141
2025
Q1
$3.86M Sell
12,393
-122
-1% -$36K 0.24% 88
2024
Q4
$3.26M Sell
12,515
-251
-2% -$74.5K 0.2% 99
2024
Q3
$4.11M Sell
12,766
-258
-2% -$84.4K 0.27% 73
2024
Q2
$4.07M Buy
13,024
+4,359
+50% +$1.28M 0.27% 75
2024
Q1
$2.46M Sell
8,665
-5,513
-39% -$1.61M 0.24% 90
2023
Q4
$4.08M Buy
14,178
+988
+7% +$269K 0.33% 65
2023
Q3
$3.54M Buy
13,190
+4,437
+51% +$1.11M 0.35% 62
2023
Q2
$1.94M Sell
8,753
-54
-0.6% -$12.5K 0.25% 93
2023
Q1
$2.13M Sell
8,807
-242
-3% -$59.4K 0.31% 78
2022
Q4
$2.38M Buy
9,049
+228
+3% +$61.1K 0.39% 68
2022
Q3
$1.99M Buy
8,821
+79
+0.9% +$19.1K 0.38% 72
2022
Q2
$2.13M Buy
8,742
+335
+4% +$82.1K 0.39% 66
2022
Q1
$2.03M Buy
8,407
+4,857
+137% +$1.12M 0.33% 69
2021
Q4
$798K Sell
3,550
-598
-14% -$126K 0.17% 136
2021
Q3
$882K Sell
4,148
-230
-5% -$52.9K 0.21% 114
2021
Q2
$1.07M Sell
4,378
-536
-11% -$132K 0.27% 91
2021
Q1
$1.22M Sell
4,914
-138
-3% -$32.9K 0.34% 74
2020
Q4
$1.16M Sell
5,052
-75
-1% -$17.3K 0.36% 72
2020
Q3
$1.3M Sell
5,127
-119
-2% -$29.5K 0.49% 48
2020
Q2
$1.24M Sell
5,246
-5,277
-50% -$1.2M 0.51% 51
2020
Q1
$2.13M Sell
10,523
-201
-2% -$43.9K 0.76% 34
2019
Q4
$2.58M Buy
10,724
+268
+3% +$59.1K 0.86% 27
2019
Q3
$2.02M Buy
10,456
+659
+7% +$126K 0.77% 34
2019
Q2
$1.81M Buy
9,797
+561
+6% +$100K 0.69% 39
2019
Q1
$1.75M Sell
9,236
-34
-0.4% -$6.49K 0.72% 40
2018
Q4
$1.8M Buy
+9,270
New +$1.81M 0.89% 33

Other funds holding AMGN

Thoroughbred Financial Services's AMGN Position: Q1 2026 in Review

Thoroughbred Financial Services increased its Amgen (AMGN) stake by 0.97% in Q1 2026, buying an estimated $23.5K and bringing the position to 6,905 shares worth $2.43M. The position accounts for 0.15% of the portfolio, ranked #136.

Thoroughbred Financial Services first reported a position in AMGN in Q4 2018 and has held it in 30 quarters since. The position peaked at $4.11M in Q3 2024. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Thoroughbred Financial Services held 6,905 shares of Amgen worth $2.43M as of Q1 2026.
  • Thoroughbred Financial Services bought 66 Amgen shares in Q1 2026, an estimated $23.5K.
  • Amgen made up 0.15% of Thoroughbred Financial Services's portfolio in Q1 2026, its #136 holding.
  • Thoroughbred Financial Services first reported a position in Amgen in Q4 2018 and has held it in 30 quarters since.
  • Thoroughbred Financial Services's Amgen position peaked at $4.11M in Q3 2024.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Thoroughbred Financial Services's 13F filing for Q1 2026, filed 12 May 2026.